Agilent Technologies, Inc. $A Position Raised by CCLA Investment Management

CCLA Investment Management boosted its position in Agilent Technologies, Inc. (NYSE:A) by 10.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,027,970 shares of the medical research company’s stock after purchasing an additional 97,312 shares during the period. Agilent Technologies makes up about 2.1% of CCLA Investment Management’s portfolio, making the stock its 25th largest holding. CCLA Investment Management owned 0.36% of Agilent Technologies worth $131,909,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in shares of Agilent Technologies by 1.8% in the second quarter. Vanguard Group Inc. now owns 33,997,845 shares of the medical research company’s stock valued at $4,012,086,000 after buying an additional 589,219 shares during the period. Massachusetts Financial Services Co. MA raised its position in Agilent Technologies by 10.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock worth $1,560,964,000 after acquiring an additional 1,273,994 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Agilent Technologies by 1.6% in the 2nd quarter. Geode Capital Management LLC now owns 7,319,530 shares of the medical research company’s stock valued at $860,137,000 after acquiring an additional 115,183 shares during the last quarter. Generation Investment Management LLP boosted its position in shares of Agilent Technologies by 15.9% during the 2nd quarter. Generation Investment Management LLP now owns 5,775,860 shares of the medical research company’s stock valued at $681,609,000 after purchasing an additional 792,304 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Agilent Technologies by 18.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company’s stock worth $448,748,000 after purchasing an additional 604,124 shares during the last quarter. 87.41% of the stock is owned by institutional investors.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $137.16 on Monday. The stock has a market cap of $38.89 billion, a PE ratio of 30.01, a price-to-earnings-growth ratio of 3.98 and a beta of 1.27. The business has a fifty day simple moving average of $145.44 and a 200-day simple moving average of $130.16. The company has a quick ratio of 1.52, a current ratio of 1.96 and a debt-to-equity ratio of 0.45. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $160.27.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, beating the consensus estimate of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The firm had revenue of $1.86 billion for the quarter, compared to analyst estimates of $1.83 billion. During the same period in the previous year, the firm earned $1.46 earnings per share. Agilent Technologies’s quarterly revenue was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. On average, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Investors of record on Tuesday, January 6th will be issued a dividend of $0.255 per share. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Tuesday, January 6th. Agilent Technologies’s dividend payout ratio is 22.32%.

Insider Activity at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 911 shares of the business’s stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $143.24, for a total transaction of $130,491.64. Following the transaction, the chief executive officer directly owned 32,058 shares of the company’s stock, valued at approximately $4,591,987.92. The trade was a 2.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, VP Rodney Gonsalves sold 3,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total transaction of $464,970.00. Following the completion of the transaction, the vice president owned 31,846 shares in the company, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 16,401 shares of company stock valued at $2,468,962. 0.26% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A has been the subject of several recent research reports. Citigroup increased their target price on shares of Agilent Technologies from $165.00 to $185.00 and gave the company a “buy” rating in a research note on Tuesday, November 25th. Evercore ISI increased their price objective on Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a research report on Tuesday, October 7th. Robert W. Baird raised their price objective on Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 25th. TD Cowen upped their target price on Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a report on Tuesday, October 14th. Finally, Barclays upgraded Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $165.00 price target for the company in a research report on Monday, December 15th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $161.77.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.